Angel News
Angel News

Back to Homepage

20th May 2022

Oxford Drug Design receives £2.2m from existing investors and angels

Oxford Drug Design Limited (ODD), a biotechnology company with a proprietary computational and machine learning platform, has raised £2.2M in funding from existing investors ACF Investors, o2h Ventures, Meltwind Advisory, a number of returning angels and new investors and the US-based R42 Group. This brings the firm’s total amount of grant and equity funding to over £10M. 

20th May 2022

Biotangents secures £2.2m to accelerate rapid disease detection tech

Biotangents, a Scottish biotechnology business, has secured £2.2m of new funding made up from £1.6m from the UK Government’s Innovate UK innovation loans programme and a further £600k from a funding round lead by the investment syndicate Kelvin Capital and with Scottish Enterprise participation to support the development and roll-out of its ‘on farm’ rapid disease detection technology.

13th May 2022

HBAN syndicates lead €1.9m investment in SymPhysis Medical

HBAN (Halo Business Angel Network) syndciates have led a €1.925M investment in Galway-based start-up, SymPhysis Medical. Angels from HBAN’s MedTech Syndicate, Irrus Investments and Boole Investment Syndicate invested a combined €925K in the company, which is developing a device that eases the discomfort and distress of fluid in the chest for cancer patients undergoing palliative care.

29th April 2022

Science Angel Syndicate backs MitoRx Therapeutics

MitoRx Therapeutics secures investment from Science Angel Syndicate to develop its first-in-class therapeutics that target dysfunctional sulfide-signalling in mitochondria to halt the progress of degenerative diseases.

Science Angel Syndicate (SAS) was launched in September 2021 to supportinvestments into frontier scientific discoveries that impact society on a global scale. Leveraging their unique due diligence capabilities they have supported SAS investors to make an investment into MitoRx Therapeutics. 

29th April 2022

52 North Health raises £1m for cancer care management device

52 North Health, a UK and US-based med-tech start-up, has raised £1 million in its first round of funding from leading UK and European specialist investors. The round was led by Cambridge Enterprise, the commercialisation arm of the University of Cambridge, with participation from Crista Galli Ventures, King’s Health Partners MedTech Innovations, Meltwind, Milltrust Ventures and a number of angels.

22nd April 2022

Femtech startup LatchAid secures £1m seed funding

SETsquared Bristol member LatchAid, an award winning breastfeeding and early parenthood support innovator, has closed its seed funding round with an ultra-competitive £510k Innovate UK Innovation Loan, bringing total investments to £1m, as testament to its ground-breaking technology and user traction.

8th April 2022

Biomedical startup Adapttech raises £2.25m from VCs and angels

Biomedical startup Adapttech has raised £2.25 million from investors including Mercia Asset Management, ACF Investors, Wren Capital and Wealth Club. The company also announced the launch of the new INSIGHT Range, a family of products that make it faster and easier to fit lower-limb prostheses and improve patient outcomes.

1st April 2022

Cambridge healthtech startup Sano Genetics raises $11m

Sano Genetics, co-founded by three University of Cambridge genomics postgraduates, has raised $11M in a Series A funding round led by MMC Ventures, with further funding from Episode 1, Seedcamp and several angel investors, including Paul Forster, a co-founder and former CEO of Indeed, Paul Wicks, former VP of innovation at PatientsLikeMe, and Margo Georgiadis, the former CEO of

18th March 2022

ACF leads £3.75m funding for fitness startup BLOK

Award-winning hybrid studio and digital fitness platform BLOK has  secured £3.75m in a funding round led by ACF Investors, with additional investment from Elcot  Capital and The Santon Group. The funding round also included investment from the UK  government’s Future Fund, Crowdcube and angel investor Rob Wirszycz, who will be joining the  business as Chairman.  

18th March 2022

Tonic Health secures investment from Henley Business Angels

Tonic Health, a natural healthcare company that combines all-in-one vitamins, minerals and plants into a drink that fuels the immune system to help end unnecessary illness, has received investment from Henley Business Angels as part of a £463,000.funding round.

4th March 2022

FluoretiQ closes £1.1 million funding round

Our member and University of Bristol spin-out, FluoretiQ, has today announced the completion of a £1.1 million, pre-series A investment. Their pioneering NANOPLEX technology is a 15-minute proprietary diagnostic platform for bacterial infections.  

25th February 2022

Semarion raises £2.14 million seed funding

Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, has closed a £2.14 million GBP seed funding round. The investment round was led by Parkwalk Advisors, with the University of Cambridge Seed Funds, Martlet Capital, and angel investors also contributing to the fundraise.

Items of 408NEXT

Back to Homepage